318 related articles for article (PubMed ID: 18247352)
1. Insights into the interactions between HIV-1 integrase and human LEDGF/p75 by molecular dynamics simulation and free energy calculation.
Zhao Y; Li W; Zeng J; Liu G; Tang Y
Proteins; 2008 Aug; 72(2):635-45. PubMed ID: 18247352
[TBL] [Abstract][Full Text] [Related]
2. Computational studies of the interaction between the HIV-1 integrase tetramer and the cofactor LEDGF/p75: insights from molecular dynamics simulations and the informational spectrum method.
Tintori C; Veljkovic N; Veljkovic V; Botta M
Proteins; 2010 Dec; 78(16):3396-408. PubMed ID: 20878714
[TBL] [Abstract][Full Text] [Related]
3. Identification of the LEDGF/p75 binding site in HIV-1 integrase.
Busschots K; Voet A; De Maeyer M; Rain JC; Emiliani S; Benarous R; Desender L; Debyser Z; Christ F
J Mol Biol; 2007 Feb; 365(5):1480-92. PubMed ID: 17137594
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75.
De Luca L; Barreca ML; Ferro S; Christ F; Iraci N; Gitto R; Monforte AM; Debyser Z; Chimirri A
ChemMedChem; 2009 Aug; 4(8):1311-6. PubMed ID: 19565598
[TBL] [Abstract][Full Text] [Related]
5. Blocking the interaction between HIV-1 integrase and human LEDGF/p75: mutational studies, virtual screening and molecular dynamics simulations.
Reddy KK; Singh P; Singh SK
Mol Biosyst; 2014 Mar; 10(3):526-36. PubMed ID: 24389668
[TBL] [Abstract][Full Text] [Related]
6. Differential interaction of HIV-1 integrase and JPO2 with the C terminus of LEDGF/p75.
Bartholomeeusen K; De Rijck J; Busschots K; Desender L; Gijsbers R; Emiliani S; Benarous R; Debyser Z; Christ F
J Mol Biol; 2007 Sep; 372(2):407-21. PubMed ID: 17669426
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory profile of a LEDGF/p75 peptide against HIV-1 integrase: insight into integrase-DNA complex formation and catalysis.
Al-Mawsawi LQ; Christ F; Dayam R; Debyser Z; Neamati N
FEBS Lett; 2008 Apr; 582(10):1425-30. PubMed ID: 18331842
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of the interactions between HIV-1 IN and the cofactor LEDGF/p75.
De Luca L; Ferro S; Morreale F; De Grazia S; Chimirri A
ChemMedChem; 2011 Jul; 6(7):1184-91. PubMed ID: 21506277
[TBL] [Abstract][Full Text] [Related]
9. Insight into the fundamental interactions between LEDGF binding site inhibitors and integrase combining docking and molecular dynamics simulations.
De Luca L; Morreale F; Chimirri A
J Chem Inf Model; 2012 Dec; 52(12):3245-54. PubMed ID: 23194297
[TBL] [Abstract][Full Text] [Related]
10. Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor.
De Luca L; Ferro S; Gitto R; Barreca ML; Agnello S; Christ F; Debyser Z; Chimirri A
Bioorg Med Chem; 2010 Nov; 18(21):7515-21. PubMed ID: 20850978
[TBL] [Abstract][Full Text] [Related]
11. Molecular modeling study on the allosteric inhibition mechanism of HIV-1 integrase by LEDGF/p75 binding site inhibitors.
Xue W; Liu H; Yao X
PLoS One; 2014; 9(3):e90799. PubMed ID: 24599328
[TBL] [Abstract][Full Text] [Related]
12. The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy.
Christ F; Debyser Z
Virology; 2013 Jan; 435(1):102-9. PubMed ID: 23217620
[TBL] [Abstract][Full Text] [Related]
13. Structure-based mutagenesis of the integrase-LEDGF/p75 interface uncouples a strict correlation between in vitro protein binding and HIV-1 fitness.
Rahman S; Lu R; Vandegraaff N; Cherepanov P; Engelman A
Virology; 2007 Jan; 357(1):79-90. PubMed ID: 16959283
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of the chromatin-binding domains of the HIV-1 integrase interactor LEDGF/p75.
Llano M; Vanegas M; Hutchins N; Thompson D; Delgado S; Poeschla EM
J Mol Biol; 2006 Jul; 360(4):760-73. PubMed ID: 16793062
[TBL] [Abstract][Full Text] [Related]
15. D77, one benzoic acid derivative, functions as a novel anti-HIV-1 inhibitor targeting the interaction between integrase and cellular LEDGF/p75.
Du L; Zhao Y; Chen J; Yang L; Zheng Y; Tang Y; Shen X; Jiang H
Biochem Biophys Res Commun; 2008 Oct; 375(1):139-44. PubMed ID: 18691555
[TBL] [Abstract][Full Text] [Related]
16. Insight into the inhibitory mechanism and binding mode between D77 and HIV-1 integrase by molecular modeling methods.
Li P; Tan JJ; Liu M; Zhang XY; Chen WZ; Wang CX
J Biomol Struct Dyn; 2011 Oct; 29(2):311-23. PubMed ID: 21875151
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for the potent inhibition of the HIV integrase-LEDGF/p75 protein-protein interaction.
Ribone SR; Quevedo MA
J Mol Graph Model; 2017 Aug; 75():189-198. PubMed ID: 28582696
[TBL] [Abstract][Full Text] [Related]
18. Fragment hopping approach directed at design of HIV IN-LEDGF/p75 interaction inhibitors.
De Luca L; Ferro S; Morreale F; Christ F; Debyser Z; Chimirri A; Gitto R
J Enzyme Inhib Med Chem; 2013 Oct; 28(5):1002-9. PubMed ID: 22803661
[TBL] [Abstract][Full Text] [Related]
19. Cyclic peptide inhibitors of HIV-1 integrase derived from the LEDGF/p75 protein.
Hayouka Z; Hurevich M; Levin A; Benyamini H; Iosub A; Maes M; Shalev DE; Loyter A; Gilon C; Friedler A
Bioorg Med Chem; 2010 Dec; 18(23):8388-95. PubMed ID: 20974536
[TBL] [Abstract][Full Text] [Related]
20. 1,4-Bis(5-(naphthalen-1-yl)thiophen-2-yl)naphthalene, a small molecule, functions as a novel anti-HIV-1 inhibitor targeting the interaction between integrase and cellular Lens epithelium-derived growth factor.
Gu WG; Ip DT; Liu SJ; Chan JH; Wang Y; Zhang X; Zheng YT; Wan DC
Chem Biol Interact; 2014 Apr; 213():21-7. PubMed ID: 24480521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
